Targacept and AstraZeneca Initiate Clinical Trial of AZD348

**Curis helping to treat cancer, neurological degenerative, kidney disorders, CUDC-101. Pathways, hedgehog, EGFR, Her2, Hsp90, Bcr-Abl/Src, CDK, BCL, MEK, VEGF, HDAC.**

Pathway 2 Curis Forum (Hedgehog and beyond) Forum Index » RSS Yahoo BIOTECH
Reply to topic
Targacept and AstraZeneca Initiate Clinical Trial of AZD348
RSS FEED


Joined: 05 Apr 2006
Posts: 19275
Post Posted: Tue Jun 10, 2008 10:26 am Reply with quote


WINSTON-SALEM, N.C.----Targacept, Inc. , a clinical-stage biopharmaceutical company developing a new class of drugs known as NNR Therapeutics , today announced the initiation of a Phase 2 clinical trial of AZD3480 in adults with Attention Deficit/Hyperactivity Disorder, or ADHD.

Read more...
View user's profileSend private message
Targacept and AstraZeneca Initiate Clinical Trial of AZD348
All times are GMT - 7 Hours  
Page 1 of 1  
  
  
Pathway 2 Curis Forum (Hedgehog and beyond) Forum Index » RSS Yahoo BIOTECH
 Reply to topic  
Forum Map
Site Map